AU2003229429A1 - Polyepitopes and mini-genes for cancer treatment - Google Patents
Polyepitopes and mini-genes for cancer treatmentInfo
- Publication number
- AU2003229429A1 AU2003229429A1 AU2003229429A AU2003229429A AU2003229429A1 AU 2003229429 A1 AU2003229429 A1 AU 2003229429A1 AU 2003229429 A AU2003229429 A AU 2003229429A AU 2003229429 A AU2003229429 A AU 2003229429A AU 2003229429 A1 AU2003229429 A1 AU 2003229429A1
- Authority
- AU
- Australia
- Prior art keywords
- polyepitopes
- mini
- genes
- cancer treatment
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37841602P | 2002-05-07 | 2002-05-07 | |
| US60/378,416 | 2002-05-07 | ||
| PCT/CA2003/000672 WO2003095642A2 (en) | 2002-05-07 | 2003-05-07 | Polyepitopes and mini-genes for cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003229429A1 true AU2003229429A1 (en) | 2003-11-11 |
Family
ID=29420399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003229429A Abandoned AU2003229429A1 (en) | 2002-05-07 | 2003-05-07 | Polyepitopes and mini-genes for cancer treatment |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003229429A1 (en) |
| WO (1) | WO2003095642A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007503834A (en) * | 2003-09-05 | 2007-03-01 | サノフィ パストゥール リミテッド | Multi-antigen vector for melanoma |
| EP3842065A1 (en) * | 2019-12-23 | 2021-06-30 | Transgene | Process for designing a recombinant poxvirus for a therapeutic vaccine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2100620A1 (en) * | 1999-09-16 | 2009-09-16 | Eisai Corporation of North America | Nucleic acids encoding polyepitope polypeptides |
-
2003
- 2003-05-07 AU AU2003229429A patent/AU2003229429A1/en not_active Abandoned
- 2003-05-07 WO PCT/CA2003/000672 patent/WO2003095642A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003095642A3 (en) | 2004-04-01 |
| WO2003095642A2 (en) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003280004A1 (en) | Hair treatment method | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| EP2671581B8 (en) | Compositions and methods for treating cancer | |
| AU2003259249A1 (en) | Pyridazinylpiperazine derivatives for treating pain | |
| AU2003226301A1 (en) | Method of treating cancer | |
| AU2003256253A1 (en) | Aerosol for medical treatment and methods | |
| AU2003224654A1 (en) | Photodynamic therapy for pre-melanomas | |
| AU2003283257A1 (en) | Scalp treatment | |
| AU2003256847A1 (en) | Method of treating cancer | |
| AU2003225535A1 (en) | Methods and compositions for treating cancer | |
| AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
| AU2003222449A1 (en) | Medicine for treating cancer | |
| AU2003232044A1 (en) | Composition and method for dermatological treatment | |
| AU2003217832A1 (en) | Catheter for treating vulnerable plaque | |
| AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
| AU2003223538A1 (en) | Methods for the treatment of cancer | |
| AU2002303230A1 (en) | Combined hydrotreating and process | |
| AU2003280558A1 (en) | Method for treatment of cancer | |
| AU2003298708A1 (en) | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| AU2003229429A1 (en) | Polyepitopes and mini-genes for cancer treatment | |
| AU2003231803A1 (en) | Treatment of cancer with mefloquire | |
| AU2003285079A1 (en) | Neurostimulation therapy manipulation | |
| AU2003296242A1 (en) | Thia-epothilone derivatives for the treatment of cancer | |
| AU2003275433A1 (en) | Compositions and methods for treating pain | |
| AU2004281077A1 (en) | Methods and agents for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
| TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 481 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AVENTISPASTEUR, LTD. , APPLICATION NO. 2003229429, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 |